Marco T Núñez Selected Research

Iron Regulatory Protein 1

1/2017	Cell death induced by mitochondrial complex I inhibition is mediated by Iron Regulatory Protein 1.
1/2016	Parkinson's Disease: The Mitochondria-Iron Link.
8/2012	The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco T Núñez Research Topics

Disease

10	Neuroblastoma 01/2017 - 07/2002
10	Parkinson Disease (Parkinson's Disease) 01/2017 - 06/2007
8	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021 - 05/2009
7	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 08/2012
5	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 08/2012
5	Iron Deficiencies 03/2012 - 08/2005
4	Inflammation (Inflammations) 01/2017 - 05/2004
4	Huntington Disease (Huntington's Disease) 01/2017 - 01/2014
3	Friedreich Ataxia (Friedreich's Ataxia) 01/2017 - 03/2015
3	Hepatocellular Carcinoma (Hepatoma) 01/2006 - 05/2004
2	Necrosis 02/2010 - 05/2004
2	Hemochromatosis (Bronze Diabetes) 08/2006 - 01/2006
1	Neuroinflammatory Diseases 05/2022
1	Cognitive Dysfunction 11/2021
1	Memory Disorders (Memory Loss) 11/2021
1	Nervous System Diseases (Neurological Disorders) 11/2021
1	Body Weight (Weight, Body) 01/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2014
1	Ataxia (Dyssynergia) 01/2014
1	Hypertrophy 02/2010
1	Neuroferritinopathy 05/2009
1	Pancreatitis 01/2006
1	Cardiomyopathies (Cardiomyopathy) 01/2006
1	Iron Overload 01/2006
1	Fibrosis (Cirrhosis) 01/2006
1	Adenocarcinoma 05/2004

Drug/Important Bio-Agent (IBA)

26	IronIBA 05/2022 - 07/2002
3	Iron Regulatory Protein 1IBA 01/2017 - 08/2012
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 02/2010
3	Proteins (Proteins, Gene)FDA Link 06/2011 - 01/2006
2	AntioxidantsIBA 01/2014 - 06/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 05/2004
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2017
1	Chelating AgentsIBA 01/2017
1	Neuroprotective AgentsIBA 01/2017
1	SulfurIBA 01/2016
1	IonsIBA 01/2014
1	MetalsIBA 01/2014
1	CytokinesIBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	HepcidinsIBA 08/2013
1	Adenosine Triphosphate (ATP)IBA 08/2012
1	Dopamine (Intropin)FDA LinkGeneric 08/2012
1	aminochrome 1 (aminochrome)IBA 08/2012
1	Ferritins (Ferritin)IBA 03/2012
1	Oxidopamine (6 Hydroxydopamine)IBA 03/2011
1	Atrial Natriuretic Factor (ANF)IBA 02/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2010
1	Actins (F Actin)IBA 02/2010
1	N- ((3- (aminomethyl)phenyl)methyl)ethanimidamideIBA 02/2010
1	ferric chlorideIBA 02/2010
1	ferric nitrilotriacetateIBA 02/2010
1	ApoferritinsIBA 05/2009
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 06/2007
1	Transcription Factors (Transcription Factor)IBA 01/2006
1	Messenger RNA (mRNA)IBA 01/2006
1	CopperIBA 08/2005
1	Glutathione (Reduced Glutathione)IBA 10/2004
1	Phospho-Specific AntibodiesIBA 06/2004
1	Cell Adhesion MoleculesIBA 05/2004
1	Ethanol (Ethyl Alcohol)IBA 05/2004

Therapy/Procedure

2	Therapeutics 11/2021 - 01/2006
1	Oral Administration 01/2017
1	Aftercare (After-Treatment) 06/2004